230 related articles for article (PubMed ID: 28758904)
1. Parathyroid hormone regulates fates of murine osteoblast precursors in vivo.
Balani DH; Ono N; Kronenberg HM
J Clin Invest; 2017 Sep; 127(9):3327-3338. PubMed ID: 28758904
[TBL] [Abstract][Full Text] [Related]
2. Sclerostin Antibody Administration Increases the Numbers of Sox9creER+ Skeletal Precursors and Their Progeny.
Balani DH; Trinh S; Xu M; Kronenberg HM
J Bone Miner Res; 2021 Apr; 36(4):757-767. PubMed ID: 33400836
[TBL] [Abstract][Full Text] [Related]
3. Withdrawal of parathyroid hormone after prolonged administration leads to adipogenic differentiation of mesenchymal precursors in vivo.
Balani DH; Kronenberg HM
Bone; 2019 Jan; 118():16-19. PubMed ID: 29800694
[TBL] [Abstract][Full Text] [Related]
4. gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation.
Standal T; Johnson RW; McGregor NE; Poulton IJ; Ho PW; Martin TJ; Sims NA
J Endocrinol; 2014 Nov; 223(2):181-90. PubMed ID: 25228504
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the action of transient and continuous PTH on primary osteoblast cultures expressing differentiation stage-specific GFP.
Wang YH; Liu Y; Buhl K; Rowe DW
J Bone Miner Res; 2005 Jan; 20(1):5-14. PubMed ID: 15619664
[TBL] [Abstract][Full Text] [Related]
6. Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells.
Rickard DJ; Wang FL; Rodriguez-Rojas AM; Wu Z; Trice WJ; Hoffman SJ; Votta B; Stroup GB; Kumar S; Nuttall ME
Bone; 2006 Dec; 39(6):1361-72. PubMed ID: 16904389
[TBL] [Abstract][Full Text] [Related]
7. Intermittent PTH treatment can delay the transformation of mature osteoblasts into lining cells on the periosteal surfaces.
Jang MG; Lee JY; Yang JY; Park H; Kim JH; Kim JE; Shin CS; Kim SY; Kim SW
J Bone Miner Metab; 2016 Sep; 34(5):532-9. PubMed ID: 26303221
[TBL] [Abstract][Full Text] [Related]
8. Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton.
Maridas DE; Rendina-Ruedy E; Helderman RC; DeMambro VE; Brooks D; Guntur AR; Lanske B; Bouxsein ML; Rosen CJ
FASEB J; 2019 Feb; 33(2):2885-2898. PubMed ID: 30354669
[TBL] [Abstract][Full Text] [Related]
9. EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone.
Takyar FM; Tonna S; Ho PW; Crimeen-Irwin B; Baker EK; Martin TJ; Sims NA
J Bone Miner Res; 2013 Apr; 28(4):912-25. PubMed ID: 23165727
[TBL] [Abstract][Full Text] [Related]
10. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
van der Horst G; Farih-Sips H; Löwik CW; Karperien M
J Bone Miner Res; 2005 Dec; 20(12):2233-44. PubMed ID: 16294276
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Bcl2 in osteoblasts inhibits osteoblast differentiation and induces osteocyte apoptosis.
Moriishi T; Maruyama Z; Fukuyama R; Ito M; Miyazaki T; Kitaura H; Ohnishi H; Furuichi T; Kawai Y; Masuyama R; Komori H; Takada K; Kawaguchi H; Komori T
PLoS One; 2011; 6(11):e27487. PubMed ID: 22114675
[TBL] [Abstract][Full Text] [Related]
12. Bone Lining Cells Could Be Sources of Bone Marrow Adipocytes.
Lee JY; Yang JY; Kim SW
Front Endocrinol (Lausanne); 2021; 12():766254. PubMed ID: 34925236
[TBL] [Abstract][Full Text] [Related]
13. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice.
Saidak Z; Le Henaff C; Azzi S; Marty C; Marie PJ
J Endocrinol; 2014 Oct; 223(1):25-33. PubMed ID: 25056116
[TBL] [Abstract][Full Text] [Related]
14. Glucose dependent miR-451a expression contributes to parathyroid hormone mediated osteoblast differentiation.
Karvande A; Kushwaha P; Ahmad N; Adhikary S; Kothari P; Tripathi AK; Khedgikar V; Trivedi R
Bone; 2018 Dec; 117():98-115. PubMed ID: 30218791
[TBL] [Abstract][Full Text] [Related]
15. Marrow adipocytes inhibit the differentiation of mesenchymal stem cells into osteoblasts via suppressing BMP-signaling.
Abdallah BM
J Biomed Sci; 2017 Feb; 24(1):11. PubMed ID: 28173811
[TBL] [Abstract][Full Text] [Related]
16. [Bone Cell Biology Assessed by Microscopic Approach. The effect of parathyroid hormone and teriparatide on bone].
Takahata M
Clin Calcium; 2015 Oct; 25(10):1529-35. PubMed ID: 26412733
[TBL] [Abstract][Full Text] [Related]
17. Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts.
Kim SW; Pajevic PD; Selig M; Barry KJ; Yang JY; Shin CS; Baek WY; Kim JE; Kronenberg HM
J Bone Miner Res; 2012 Oct; 27(10):2075-84. PubMed ID: 22623172
[TBL] [Abstract][Full Text] [Related]
18. PTH-Induced Osteoblast Proliferation Requires Upregulation of the Ubiquitin-Specific Peptidase 2 (Usp2) Expression.
Shirakawa J; Harada H; Noda M; Ezura Y
Calcif Tissue Int; 2016 Mar; 98(3):306-15. PubMed ID: 26643174
[TBL] [Abstract][Full Text] [Related]
19. Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitor.
Kulkarni NH; Wei T; Kumar A; Dow ER; Stewart TR; Shou J; N'cho M; Sterchi DL; Gitter BD; Higgs RE; Halladay DL; Engler TA; Martin TJ; Bryant HU; Ma YL; Onyia JE
J Cell Biochem; 2007 Dec; 102(6):1504-18. PubMed ID: 17520664
[TBL] [Abstract][Full Text] [Related]
20. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
Brixen KT; Christensen PM; Ejersted C; Langdahl BL
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
